Pediatrics
Cystic fibrosis
One ion channel explains salty sweat, retained airway mucus and poor pancreatic digestion. Begin with the organ in the question, then connect it to CFTR.
Partially covered in the main question banks · 2 main-bank entries · 30 linked PDF entries · 4 generated drills
Prerequisites and related lessons
- Constipation
- Cholestasis in pediatrics
Curriculum reference · Official College Textbook – Digestive Disorders – Part 1, pp. 127–128. Lesson adapted from Allergy, bleeding and cystic fibrosis.
Topic map
- Geneautosomal recessive CFTR dysfunction
- Airways and pancreasdehydrated secretions and obstruction
- Sweatpoor ductal salt reabsorption
- ScreenIRT, diagnose → sweat chloride and CFTR evaluation
Scroll the diagram to see all labels.
Definition, inheritance and mechanism
Cystic fibrosis (CF) is a multisystem disorder from disease-causing variants affecting CFTR, the cystic fibrosis transmembrane conductance regulator [Pediatric Mid Q1/Q19 · Old p. 75]. The gene is on chromosome 7. Standard inheritance is autosomal recessive [Pediatric Mid Q2]: with two carrier parents, each pregnancy has a 1-in-4 chance of CF, 1-in-2 carrier chance and 1-in-4 chance of inheriting neither familial variant. CFTR conducts chloride [Old p. 75 Q2] and bicarbonate at epithelial surfaces. F508del is a common processing variant. The phenotype varies by genotype and other factors.
In airways and pancreatic ducts, impaired salt and bicarbonate secretion makes fluid abnormally viscous. Mucus stays in the airway and pancreatic ducts plug. In a sweat duct, CFTR normally reabsorbs chloride. Reduced reabsorption makes sweat salty and increases losses in heat or illness. These are different effects of the same channel in different epithelia.
Respiratory and upper airway manifestations
Recurrent chest infections [Pediatric Mid Q4/Q19], chronic wet cough, airway obstruction and bronchiectasis are classic. Bronchiectasis means permanently dilated damaged airways, which retain secretions and promote repeated infection. Commonly encountered bacteria include Staphylococcus aureus and Pseudomonas aeruginosa, with patterns varying by age and patient. Advanced disease can cause digital clubbing [Pediatric Mid Q8], hemoptysis, pneumothorax or respiratory failure. The upper airway clues are nasal polyps and chronic sinus disease [Pediatric Mid Q5/Q6/Q19] from poor mucus clearance and recurrent inflammation.
Gastrointestinal and systemic manifestations
Meconium ileus [Pediatric Mid Q3] is distal small-bowel obstruction by unusually thick meconium, presenting with neonatal distension, poor passage of meconium and sometimes bilious vomiting. Contrast imaging may show microcolon because the distal colon has not been used. In selected uncomplicated cases a specialist contrast enema may relieve obstruction, while perforation, volvulus, atresia or failed nonoperative reduction may require surgery. Distinguish this from Hirschsprung disease, where distal aganglionosis prevents normal relaxation. Older patients can develop distal intestinal obstruction syndrome from inspissated contents near the ileocecal region.
Exocrine pancreatic insufficiency [Pediatric Mid Q7 · Old p. 87 Q1] means too few digestive enzymes reach the bowel. Fat maldigestion leads to steatorrhea [Old p. 87 Q1] (bulky oily foul stools), fat-soluble vitamin deficiency and poor growth. Increased energy needs from chronic disease compound failure to thrive [Pediatric Mid Q9/Q19]. Pancreatic-sufficient patients can have other manifestations, including pancreatitis. Additional complications include CF-related hepatobiliary disease, diabetes mellitus [Pediatric Mid Q10] from impaired insulin secretion with variable insulin resistance, low bone density and male infertility through congenital bilateral absence of the vas deferens. Salt loss and dehydration [Pediatric Mid Q11] can lead to hypochloremic alkalosis in hot conditions or illness.
Screening, confirmation and assessment
- Initial assessment
- IRT on newborn screen or clinical/family suspicion
- Confirmation or next test
- Quantitative sweat chloride and selected repeat, genetic or functional testing
Newborn screening starts with elevated immunoreactive trypsinogen (IRT) on dried blood [Pediatric Mid Q12/Q14]. A positive screen needs diagnostic testing. Programs may combine IRT with a repeat screen or CFTR analysis. A quantitative sweat chloride test [Pediatric Mid Q13] measures chloride in collected sweat after pilocarpine iontophoresis. In an appropriate clinical context, ≥60 mmol/L supports CF, 30–59 mmol/L is intermediate and <30 mmol/L makes CF less likely. Positive or equivocal results are managed with an experienced center, repeat testing or molecular/functional testing as indicated. Two disease-causing variants in trans can support diagnosis in context. A negative limited panel does not exclude CF when suspicion remains.
Assess pancreatic function with fecal elastase and clinical nutrition, growth and stool features. Evaluate airway infection by respiratory cultures and pulmonary status by spirometry when age-appropriate. Consider vitamin, liver and glucose surveillance according to age and clinical status. Screening for CF-related diabetes often uses an oral glucose tolerance test from age 10 under CF care.
Management and follow-up
Airway infection treatment [Pediatric Mid Q15] and airway clearance are cornerstones. Use individualized chest physiotherapy, activity, and selected mucus therapies such as dornase alfa or hypertonic saline. Respiratory cultures and clinical course guide antibiotics for exacerbations, eradication or chronic infection, with infection-control practices at CF centers. CFTR modulators improve the function of eligible variant proteins. Selection depends on age, genotype and local approval. Book I mentions gene therapy as a research strategy, distinct from established modulator treatment.
Support growth with nutrition and activity [Pediatric Mid Q16], tailored energy and protein intake, and salt/fluid planning. Give pancreatic enzyme replacement therapy (PERT) [Pediatric Mid Q17] with meals and snacks when pancreatic insufficiency is present, adjusting with CF professionals. Avoid unnecessary dose escalation because very high dosing has been associated with fibrosing colonopathy. Replace and monitor fat-soluble vitamins A, D, E and K [Pediatric Mid Q18]. Provide multidisciplinary care for respiratory, metabolic, gastrointestinal and psychosocial needs, and family counseling.
Exam traps
IRT screens, sweat chloride assesses CFTR dysfunction, and genotyping characterizes variant status. Steatorrhea in CF is typically from intraluminal enzyme deficiency; celiac disease injures the small-bowel mucosa. Osmotic diarrhea often improves with fasting, whereas secretory diarrhea tends to persist. A B12 deficiency from lack of intrinsic factor uses a different mechanism from CF fat-soluble vitamin deficiency.
Diagnostic and management pathways
- Positive screen, suggestive phenotype or family history → sweat chloride at an experienced center
- Intermediate or discordant testing → repeat and assess CFTR variants/function
- Confirmed CF → assess pulmonary and pancreatic status, nutrition and complications
- Individualize airway care, PERT and supplements if indicated, genotype-directed therapy and longitudinal surveillance
Compare at a glance
| Clue | CF explanation | Important alternative |
|---|---|---|
| Delayed meconium plus inspissated ileal contents | Meconium ileus | Hirschsprung disease, meconium plug, atresia |
| Greasy stools and poor growth | Pancreatic enzyme deficiency | Celiac mucosal malabsorption |
| Wet cough and recurrent infections | Airway retention and bronchiectasis | Primary ciliary dyskinesia, immunodeficiency |
| Positive IRT | Screening signal | Confirm with sweat testing and further evaluation |
Short-answer practice
Explain why cystic fibrosis can cause both salty sweat and steatorrhea.
A CFTR defect impairs chloride reabsorption in sweat ducts. In pancreatic ducts, reduced fluid and bicarbonate secretion promotes plugging. Too few digestive enzymes reach the gut, so dietary fat remains in the stool.
Supplementary clarification – not directly stated in the uploaded materials. Clinical references · Cystic Fibrosis Foundation diagnostic guideline · Cystic Fibrosis Foundation pancreatic enzymes guideline · Cystic Fibrosis Foundation care guidelines
Exam words
- CFTR, the cystic fibrosis transmembrane conductance regulator [Pediatric Mid Q1/Q19 · Old p. 75]
- autosomal recessive [Pediatric Mid Q2]
- chloride [Old p. 75 Q2]
- Recurrent chest infections [Pediatric Mid Q4/Q19]
- digital clubbing [Pediatric Mid Q8]
- nasal polyps and chronic sinus disease [Pediatric Mid Q5/Q6/Q19]
- Meconium ileus [Pediatric Mid Q3]
- Exocrine pancreatic insufficiency [Pediatric Mid Q7 · Old p. 87 Q1]
- steatorrhea [Old p. 87 Q1]
- failure to thrive [Pediatric Mid Q9/Q19]
- diabetes mellitus [Pediatric Mid Q10]
- Salt loss and dehydration [Pediatric Mid Q11]
- elevated immunoreactive trypsinogen (IRT) on dried blood [Pediatric Mid Q12/Q14]
- quantitative sweat chloride test [Pediatric Mid Q13]
- Airway infection treatment [Pediatric Mid Q15]
- nutrition and activity [Pediatric Mid Q16]
- pancreatic enzyme replacement therapy (PERT) [Pediatric Mid Q17]
- fat-soluble vitamins A, D, E and K [Pediatric Mid Q18]
Practice questions
Rapid revision sheet
Sixty-second recall. Say the definition, the key clue and the next clinical step out loud before checking the list.
- CFTR, the cystic fibrosis transmembrane conductance regulator [Pediatric Mid Q1/Q19 · Old p. 75]
- autosomal recessive [Pediatric Mid Q2]
- chloride [Old p. 75 Q2]
- Recurrent chest infections [Pediatric Mid Q4/Q19]
- digital clubbing [Pediatric Mid Q8]
- nasal polyps and chronic sinus disease [Pediatric Mid Q5/Q6/Q19]
Official College Textbook – Digestive Disorders – Part 1, pp. 127–128
Active recall
How does cystic fibrosis cause steatorrhea and poor weight gain?
Thick secretions obstruct pancreatic ducts, reducing delivery of digestive enzymes and causing maldigestion, particularly of fat.
Official College Textbook – Digestive Disorders – Part 1, pp. 127–128
Recall the diagnostic and management pathway from memory.
Start with the presenting clue, name the first assessment, then distinguish confirmation, immediate management and follow-up.
- Positive screen, suggestive phenotype or family history → sweat chloride at an experienced center
- Intermediate or discordant testing → repeat and assess CFTR variants/function
- Confirmed CF → assess pulmonary and pancreatic status, nutrition and complications
- Individualize airway care, PERT and supplements if indicated, genotype-directed therapy and longitudinal surveillance